Many individuals have been penalized and will be listed as *ST! Orient Group Incorporation is on the "brink of life and death" | Quick read announcement.
① Orient Group Incorporation received the "Notice of Administrative Penalty" from the Securities Regulatory Commission, and several people including the actual controller Sun Hongwei were penalized; ② The company's Stocks were suspended from trading on March 17, and resumed trading on March 18 with a delisting risk warning.
Shanghai Xuerong Bio-Technology changes ownership, new actual controller sets a "hundred billion Market Cap" flag | Quick read announcement.
① The control of Shanghai Xuerong Bio-Technology has changed, with chairman Yang Yongping relinquishing the position of the company's controlling Shareholder and actual controller. ② Jiang Zhi, an entrepreneur from the Online Games industry, will become the new actual controller. He stated that he hopes to build Shanghai Xuerong Bio-Technology into a publicly traded company with a revenue of 10 billion and a Market Cap of 100 billion in the next 3 to 5 years.
The Chairman is under investigation, Wanchen Group: the matters involved are unrelated to the company's Operation | Brief announcement.
① Wancheng Group announces that Chairman Wang Jiankun has been placed under detention and is under investigation; the matters involved are unrelated to the company, and so far the company has not been asked to assist in the investigation. ② Reviewing Wang Jiankun's tenure, during his time, he promoted the transformation of Wancheng Group from edible mushroom cultivation to wholesale snack business.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Suspected of major financial fraud! Orient Group Incorporation is currently at risk of being (Delisted). How can the rights of 0.129 million Shareholders be protected?
① The China Securities Regulatory Commission reported that it has preliminarily determined that the financial information disclosed by Orient Group Incorporation from 2020 to 2023 is severely inaccurate, suspected of significant financial fraud, which may involve serious violations that lead to (Delisted); ② As of the end of the third quarter of 2024, Orient Group Incorporation still has 0.129 million Shareholders, raising concerns about how investors can protect their legal rights.
Haoxiangni faces a difficult profitability dilemma, expecting net income to be in the red for three consecutive years | Interpretations
① Haoxiangni expects a net income loss of between 52 million yuan and 75 million yuan last year, marking the third consecutive year of losses; ② Based on the third-quarter report, the revenue growth of Haoxiangni is accompanied by high sales expenses. ③ With the support of concepts such as 'WeChat Small Shop', Haoxiangni has recently been favored in the secondary market, but the company indicates that the income from this channel is relatively low.